Cormorant Asset Management »

Newamsterdam Pharma Co Nv shares owned by Cormorant Asset Management

Quarter-by-quarter ownership of Newamsterdam Pharma Co Nv (NAMS) shares owned by Cormorant Asset Management from 13F filings

Historical chart of Cormorant Asset Management investment in Newamsterdam Pharma Co Nv

Tip: Access up to 7 years of quarterly data

All positions including Newamsterdam Pharma Co Nv held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Newamsterdam Pharma Co Nv by Cormorant Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $84M 3.3M 25.70
2024-09-30 $41M 2.5M 16.60
2024-06-30 $44M 2.3M 19.21
2024-03-31 $36M 1.5M 23.65

More positions owned by Cormorant Asset Management

Moonlake Immunotherapeutics Class A Ord (MLTX)
Praxis Precision Medicines I Com New (PRAX)
Janux Therapeutics (JANX)
Arcellx Common Stock (ACLX)
Edgewise Therapeutics (EWTX)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Eyepoint Pharmaceuticals Com New (EYPT)
Rapport Therapeutics (RAPP)
Crinetics Pharmaceuticals In (CRNX)
Insmed Com Par $.01 (INSM)
Bridgebio Pharma (BBIO)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Bright Minds Biosciences Com New (DRUG)
Vaxcyte (PCVX)
Merus N V (MRUS)

View all positions for Cormorant Asset Management

Top funds holding Newamsterdam Pharma Co Nv

Frazier Life Sciences Management
Fcpm Iii Services B.v.
Bain Capital Life Sciences Investors
RA Capital Management
Viking Global Investors
Deerfield Management Company
Jennison Associates
Cormorant Asset Management
Medicxi Ventures Management
Woodline Partners
Wellington Management Company
Capital Research and Management Company - Division 3
Alliancebernstein
Henderson Group
Polar Capital Holdings

View all funds holding Newamsterdam Pharma Co Nv